CALL US:
0161 773 4477

Transformation

0 £0.00

You have no items in your Shopping Basket.

APPROVED BY LEADING MEDICAL EXPERTS

100% MONEY BACK GUARANTEED

DISCREET PACKAGING ON ALL OUR ITEMS

CALL US: 0161 773 4477
  1. Home
  2. Female Hormones
  3. Breast & Nipple Development
  4. Aspire Female Breast & Nipple Enlargement Combination Hormone Gel
Alternative Image Hover to zoom, click to Enlarge

Aspire Female Breast & Nipple Enlargement Combination Hormone Gel

£149.00
ASP003-3MTH

Aspire Breast and Nipple Gel contains the latest micronised molecular formula which significantly improves the absorption of the active ingredients. Breast and nipple enlargement combi gel with new micronised active ingredients combines two treatments into a economical single product. Supplied in 3-month treatment packs

  1. Supply
Qty: In Stock
Add to Basket
  • Product Detail
  • Directions of Use
  • Delivery and Returns
  • Ask us a Question

This new micronised formula delivered a 68% improved absortion in trials & is supplied in 3-month treatment packs

Rub a small amount to both breasts and nipples until it is full absorbed. You will also need to purchase both an anti-androgen to suppress your testosterone levels and transdermal hormone skin prep to ensure effective absorption by removing natural skin barrier oils and dead skin cells.

We want you to be fully satisfied with your purchase and as with all other items it comes with our unique 100% guarantee.
 
If you do not want the goods you have received then please return them by recorded delivery stating whether you wish to exchange, receive a credit note or receive a refund via your original payment channel.
 
It would help us to constantly improve our service if you would kindly state your reason for returning the goods.

Please feel free to ask us any questions you may have about this product. We are always here to help you. Don’t forget to include the product name.
Send your email to questions@transformation.co.uk

Customer Reviews

This product has not been reviewed yet.